Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov-Dec;15(6):707-710.
doi: 10.5005/jp-journals-10005-2451.

Dental Considerations for the Treatment of Patients with Morquio Syndrome

Affiliations

Dental Considerations for the Treatment of Patients with Morquio Syndrome

Anju Vinod et al. Int J Clin Pediatr Dent. 2022 Nov-Dec.

Abstract

Aim: Morquio syndrome, also called Mucopolysaccharidosis IV (MPS IV), is a rare autosomal recessive metabolic lysosomal disorder that results in the deposition of glycosaminoglycans (GAGs) in various tissues and organs, resulting in an array of signs and symptoms. The aim of the study was to systematically record the clinical features with a special emphasis on oral manifestations of patients diagnosed with MPS IV and asses the dental treatment implications of the disease manifestations.

Materials and methods: A cross-sectional study was conducted on patients diagnosed with MPS IV (n = 26). A complete clinical and oral examination was done and the findings were systemically recorded.

Results: The study showed that the patients diagnosed with MPS IV have multiple treatment challenges owing to the range of disease manifestations. Furthermore, they have higher oral health care needs because of the anatomical and pathological changes.

Conclusion and clinical significance: Dental professionals must be aware of the implications of the disease manifestation and their accompanying challenges while treating patients with MPS IV. The oral health needs are higher for these patients and regular dental evaluation and treatment must be incorporated into their health care regimen.

How to cite this article: Vinod A, Raj SN, Anand A, et al. Dental Considerations for the Treatment of Patients with Morquio Syndrome. Int J Clin Pediatr Dent 2022;15(6):707-710.

Keywords: Morquio syndrome; Mucopolysaccharidosis; Oral health needs; Treatment implications.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

References

    1. Rekka P, Rathna PV, Jagadeesh S, et al. Mucopolysaccharidoses type IV A (Morquio syndrome): a case series of three siblings. J Indian Soc Pedod Prev Dent. 2012;30(1):66–69. doi: 10.4103/0970-4388.95586. - DOI - PubMed
    1. Kliegman Robert M, Geme ST, Behrman S. Nelson's Essentials of Pediatrics. 19th edition, Vol. 1. Philadelphia: W.B Saunders; 2012. pp. 509–516. Vol.
    1. Leadley RM, Lang S, Misso K, et al. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis. 2014;9(1):173. doi: 10.1186/s13023-014-0173-x. - DOI - PMC - PubMed
    1. Neufeld EF, Muenzer J. In: The Metabolic and Molecular Bases of Inherited Disease. 7th edition. Scriver CR, Beaudet AL, Sly WS, Valle D, editors. New York: McGraw-Hill; 1995. The mucopolysaccharidoses- a lysosomal storage disorder. p. 2465. (Eds.),
    1. Sheiham A. Oral health, general health and quality of life. Bull World Health Organ. 2005;83(9):644. doi: 10.1590/S0042-96862005000900004. - DOI - PMC - PubMed

LinkOut - more resources